美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

AdvisorShares Psychedelics ETF

20.51

-0.7400-3.48%

成交量：1.53万

成交额：31.51万

市值：4,419.86万

市盈率：- -

高：21.10

开：21.10

低：20.47

收：21.25

52周最高：27.02

52周最低：15.63

股本：215.50万

流通股本：215.50万

量比：1.04

换手率：0.71%

股息：1.68

股息率：8.21%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

NRX制药旗下NRX Defense Systems获美国国防高级研究计划局1100万美元主承包合同，评估机器人磁刺激联合NRX-101治疗难治性抑郁症

BUZZ——美国股市动态-埃森哲、Arhaus、Alkermes

阿尔凯默斯宣布ALKS 7290治疗成人注意力缺陷多动障碍（ADHD）的1B期临床概念验证取得积极成果

Compass Pathways在2026年精神病学大会上于美国启动‘改变难治性抑郁症的旋律’项目，深化医疗专业人士认知

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/PSIL"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":20.51,"timestamp":1791913332348,"preClose":21.25,"halted":0,"volume":15260,"delay":0,"changeRate":-0.034823529411764635,"floatShares":2154976,"shares":2154976,"eps":0,"marketStatus":"交易中","change":-0.74,"latestTime":"10-13 13:42:50 EDT","open":21.095,"high":21.1,"low":20.4732,"amount":315068.00107999996,"amplitude":0.029496,"askPrice":20.64,"askSize":100,"bidPrice":20.31,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":21.25,"sharesOutstanding":1184976,"nav":21.742,"aum":46852860.14,"dividendRate":0.082058,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.25,"preClose":21.25,"latestTime":"19:30 EDT","volume":40,"amount":841.73,"timestamp":1791847803489,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.036991,"impliedVol":0.3624,"impliedVolPercentile":0.5179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2154976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.036991,"shares":2154976,"dividePrice":1.683,"high":21.1,"amplitude":0.029496,"preClose":21.25,"low":20.4732,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":20.51,"eps":0,"divideRate":0.082058,"volume":15260,"delay":0,"ttmEps":0,"open":21.095,"prevYearClose":17.17,"prevWeekClose":21.765,"prevMonthClose":22.5,"prevQuarterClose":22.5,"fiveDayClose":21.24,"twentyDayClose":24.5,"sixtyDayClose":24.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171089399","title":"NRX制药旗下NRX Defense Systems获美国国防高级研究计划局1100万美元主承包合同，评估机器人磁刺激联合NRX-101治疗难治性抑郁症","url":"https://stock-news.laohu8.com/highlight/detail?id=1171089399","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171089399?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:01","pubTimestamp":1790766071,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals Inc.（纳斯达克代码：NRXP）旗下NRX Defense Systems获得美国国防高级研究计划局（DARPA）价值1100万美元的主承包合同，将评估机器人磁刺激与NRX-101联合用于难治性抑郁症的治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168093","title":"BUZZ——美国股市动态-埃森哲、Arhaus、Alkermes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168093","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168093?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 19:52","pubTimestamp":1789991558,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-埃森哲、Arhaus、Alkermes工作区中用于查询单只股票走势的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月21日-周一，受人工智能类股领涨推动，华尔街期货走高；与此同时，油价下跌2%拖累国债收益率走低，因有迹象表明中东交战各方对达成和解持开放态度","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4S45D0SA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2381873111.SGD","BK4127","LU0265550946.USD","BK4108","CUE","HOOW","COIG","BK4534","BULU","LU1823568750.SGD","CRMX","MSST","FDIG","ROBN","HOOD","LU1366333091.USD","MST","LU1861220207.SGD","BK4168","BK4566","MTYY","SGXZ31699556.SGD","BK4585","BK4139","SG9999018857.SGD","HOOX","HOOZ","LU1116320737.USD","LU0545562505.USD","MEDX","LU0511384066.AUD","SG9999017495.SGD","SGXZ23171101.USD","PSKY","LU1235294995.USD","LU0175139822.USD","CRMU","MSTW","MSTX","BK4516","MSTU","MSDD","IE00BHPRN162.USD","BK4125","BK4533","LU0342679015.USD","MSTZ","LU0323239441.USD","MSOO","BK4595","LU0130517989.USD","FINX","LU0949170772.SGD","LU1201861249.SGD","LU1861217088.USD","IAI","IE00B7KXQ091.USD","ACN","LU1430594728.SGD","BK4213","BULL","LU0289961442.SGD","LU1989772923.USD","HOYY","COII","LU0323240290.USD","IE0004445015.USD","CRML","DAPP","BULG","IE00BFSS7M15.SGD","BK4547","BK4551","BK4112","LU1883839398.USD","FBT","BITQ","APED","LU1861559042.SGD","LU1894683264.USD","BLCK","GLND","COIX","IE00BJJMRY28.SGD","LU1585245621.USD","LU0868494617.USD","MSTR","SG9999014914.USD","IBRN","BK4561","07399","WBD","MSII","HOOG","07799","LU0265550359.USD","3SMI.UK","HK0000819398.USD","COYY","BKCH","LU0157215616.USD","LU1003077747.HKD","LU1989772840.SGD","BK4554","LU0081259029.USD","LU1116320901.HKD","CONI","LU0738911758.USD","HOOI","LU1506573853.SGD","LU0942090050.USD","HODU","09311","PSCH","LU0868494708.USD","BK4178","BK4588","BPAY","LU0130102774.USD","COIW","BK4598","SG9999014880.SGD","CONX","COIA","FIAT","LU1861558580.USD","SMI3.UK","IE00BJJMRX11.SGD","LU0545039389.USD","IMST","LU2133065610.SGD","HOOC","LU1894683348.USD","SG9999018865.SGD","LU1228905037.USD","SG9999014906.USD","GRML","IBLC","IE00BFSS8Q28.SGD","07311","CONL","LU2211815571.USD","WNTR","BK4596","COIO","CRPT","LU1032466523.USD","SG9999014898.SGD","MSTP","HOII","SMST","IE00BSNM7G36.USD","LU0553294199.USD","OWNB","MSTK","LU1228905540.USD","PSIL","07711","LU2596442595.SGD","ARHS","LU0289960550.SGD","COIN","SG9999004303.SGD","MSTY.UK","09399","BK4581","IE000M9KFDE8.USD","LU2360107671.USD","LU1046421795.USD","LU0648001328.SGD","ALKS","BK4539","CONY","HOOY","REXC","LU2247934214.USD","LU0477156953.USD","BK4600","MSTC","MSTY","BK4134","09799","09711","LMI3.UK","LU0980610538.SGD","LU0661504455.SGD","LU0149725797.USD","LU0289739343.SGD","BK4535","ICOI","3LMI.UK","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142420523","title":"阿尔凯默斯宣布ALKS 7290治疗成人注意力缺陷多动障碍（ADHD）的1B期临床概念验证取得积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1142420523","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142420523?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 19:01","pubTimestamp":1789988473,"startTime":"0","endTime":"0","summary":"阿尔凯默斯今日披露了一项振奋人心的阶段性成果——其试验性药物ALKS 7290在针对成人注意力缺陷多动障碍的1B期临床研究中，成功达成了临床概念验证。这标志着该候选药物迈出了关键性的一步。该研究旨在评估ALKS 7290在成人ADHD患者群体中的安全性、耐受性及初步疗效信号。阿尔凯默斯表示，将基于这些数据，迅速推进ALKS 7290进入下一阶段临床研究，以更全面、深入地验证其疗效与长期安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","PSIL","ALKS","FBT","PSCH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111501056","title":"Compass Pathways在2026年精神病学大会上于美国启动‘改变难治性抑郁症的旋律’项目，深化医疗专业人士认知","url":"https://stock-news.laohu8.com/highlight/detail?id=1111501056","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111501056?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 18:31","pubTimestamp":1789468272,"startTime":"0","endTime":"0","summary":"在即将召开的2026年精神病学大会上，COMPASS Pathways plc正式宣布于美国市场推出全新倡议——“改变难治性抑郁症的旋律”。该项目的核心目标在于拓宽医疗保健专业人士对难治性抑郁症的理解边界，推动临床认知的迭代升级。在2026年精神病学大会这一汇聚全球精神健康领域顶尖专家的平台上，该项目无疑将占据重要位置。COMPASS Pathways此举，也标志着其在推动精神健康治疗创新道路上迈出了坚实一步，超越了药物研发本身，深入到医疗生态系统的神经中枢。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PSIL\",params:#limit:6,delay:false,,,undefined,":[]}}